Kaisa Health Group (00876.HK): Liu Lihao Resigns as Executive Director, Yang Feng Appointed

newtimespace.com reports, Kaisa Health Group Holdings Limited (Stock Code: 0876) announced that Mr. Liu Lihao has resigned as executive director due to other work arrangements, effective from 13 July 2026. Mr. Liu has confirmed that he has no disagreements with the board and there are no matters relating to his resignation that need to be brought to the attention of shareholders or the Stock Exchange. The board is pleased to announce that Mr. Yang Feng has been appointed as executive director, effective from 13 July 2026. Mr. Yang, aged 52, is the president of Qinghai Pharmaceutical Co., Ltd., a subsidiary of the company, responsible for the overall operation and management of Qinghai Pharmaceutical. He joined Qinghai Pharmaceutical in 2021 and has served as chief strategy officer, vice chairman, senior vice president and president. Mr. Yang graduated from Xinjiang Medical University with a bachelor's degree. He has entered into a service contract with the company for a term of three years from 13 July 2026 to 12 July 2029, with director's remuneration of HK$100,000 per annum (before tax). As at the date of this announcement, Mr. Yang does not have and is not deemed to have any interest in any shares or related shares of the company or its associated corporations as defined under Part XV of the Securities and Futures Ordinance.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.